Healthcare - Page 1 | TalkMarkets
All Posts > Content under Healthcare
1 to 16 of 4324 Posts
1 2 3 ... 271
5 Stocks To Bet On New Analyst Coverage
Article By: Zacks Investment Research
Monday, August 21, 2017 12:32 PM EDT
As analysts are one of the most important information intermediaries in capital markets, initiation of coverage by them creates value for companies.
In this article: CMCO, ACET, CNCE, APPF, FWONA
Post Noon Sell-Off; Infosys Falls 5.4%
Article By: Equitymaster India
Monday, August 21, 2017 7:15 AM EDT
Among BSE sector indices, IT index weighed down by Infosys, fell by 2%, followed by PSU stocks 1.8%, and healthcare stocks 1.6%. Infosys, BHEL, and Bank of Baroda were the top losers, while Axis Bank, M&M and Tech Mahindra were the top gainers.
In this article: INFY Also: INDY, EPI, INDA, DAX
4 Stocks To Buy As Q2 Earnings Season Nears Close
Article By: Zacks Investment Research
Sunday, August 20, 2017 3:32 PM EDT
As the second-quarter earnings season is almost coming to an end, we have picked stocks that have displayed historical earnings growth and are also seeing a rise in quarterly and annual earnings estimates
In this article: EW, MGA, NVDA, SP
Week In Review: How Trump's Policies Moved Stocks - Sunday, August 20
Article By: The Fly
Sunday, August 20, 2017 7:02 AM EDT
President Donald Trump's American Manufacturing Council was in the spotlight this week as several CEO announced their departures, leading to its dissolvement.
In this article: DIS, GM, HUM, JNJ, JPM, MRK, UA, AMZN, INTC, TSLA
Weighing The Week Ahead: Is A Market-Friendly Policy Agenda In Peril?
Article By: Jeff Miller
Sunday, August 20, 2017 3:45 AM EDT
It is a modest economic calendar, with continuing summer vacations for many. Will there finally be a quiet week? I am especially interested in New Home Sales.
In this article: WBA, AXP, GE, SYF, CVS, DG, WMT, BRK-B, OHI
51 Firms Going Ex-dividend Next Week, Including Aflac, Southwest And Johnson & Johnson
Article By: Timothy J. McIntosh
Saturday, August 19, 2017 6:40 PM EDT
There are several well known large cap stocks going ex-dividend next week. Ex-dividend dates are important to dividend investors because one must own a stock on its ex-dividend date in order to be eligible to receive its next dividend.
In this article: AFL, DFS, JNJ, LUV
Week In Review: China's Life Science Deals Top $1.4 Billion For Week
Article By: ChinaBio® Today
Saturday, August 19, 2017 2:57 PM EDT
Harbin Gloria Pharma and WuXi Biologics have entered an ex-China agreement for a PD-1 antibody with Arcus Biosciences of California's Bay Area in a deal worth up to $818 million.
In this article: LLY, MVRBF, PFSCF, CELG
Biotech Digest – GMED Receives Clearance, BIOC Inks New Collaboration, PFE Receives Approval
Article By: KKD Healthcare Analytics
Friday, August 18, 2017 2:03 PM EDT
Globus Medical Inc. stock perked up as the company announced receiving the 510 (k) clearance from the FDA for Excelsius GPS. AstraZeneca announced receiving the FDA approval for its Lynparzaa. Pfizer has FDA approval for its Besponsa.
Citi Sees Advantage For Tesaro Despite Broad Lynparza Label
Article By: The Fly
Friday, August 18, 2017 6:00 AM EDT
Citi analyst Robyn Karnauskas says the "broad label" given yesterday to AstraZeneca's Lynparza increases competition for Tesaro.
In this article: AZN, TSRO Also: CLVS
Health Insurance Innovations - Chart Of The Day
Article By: Jim Van Meerten
Thursday, August 17, 2017 2:00 PM EDT
The Chart of the Day belongs to Health Insurance Innovations. Since the Trend Spotter signaled a buy on 5/4 the stock gained 71.07%.
In this article: HIIQ
Immunotherapy Company's Q2 Revenue 'Handily Beats' H.C. Wainwright's Projection
Article By: The Life Sciences Report
Thursday, August 17, 2017 1:17 PM EDT
Inovio Pharmaceuticals Inc. exited Q2/17 with $92 million in cash. It has closed a public offering that yielded $70.5 million, which "would be used for general corporate purposes, including clinical trial expenses.
In this article: INO
The Cannabis Distribution Quagmire In Nevada Has Caused A Sharp Decline In Sales
Article By: Technical420
Thursday, August 17, 2017 1:09 PM EDT
Shortly after Nevada's recreational marijuana program launched in July, a state of emergency was reported when dispensaries did not have enough product to support demand.
In this article: VPGDF
Can Pfizer Bank On New Immunotherapy Bavencio For Growth?
Article By: Zacks Investment Research
Thursday, August 17, 2017 12:59 PM EDT
As demand for immuno-oncology drugs and their combinations rises, Pfizer, Inc.’s newly approved immunotherapy, Bavencio, is being considered a significant top-line driver for this New York-based pharma giant.
In this article: PFE Also: AZN, MRK, NVS
These 5 Stocks Are Facing Trump’s Firing Line
Article By: TipRanks
Thursday, August 17, 2017 10:48 AM EDT
Stocks that face the wrath of Trump may see share prices crashing.
In this article: MRK, INTC, UA, TSLA, IBM Also: AMZN
Why Diligence Matters: Don’t Buy Acadia Healthcare’s Roll-Up
Article By: David Trainer
Wednesday, August 16, 2017 12:48 PM EDT
Acadia operates in the Behavioral Healthcare field, which focuses on treating people with mental illness and addiction. The industry is fairly fragmented, and the bull case for Acadia has rested on the idea that it can reap gains.
In this article: ACHC
E Kindred Healthcare Not A Good Bet For Individual Investor
Article By: Kate Hayden
Wednesday, August 16, 2017 11:58 AM EDT
Less than 5% of KND is held by individual investors, and the recent changes to its core mission underline why this is one best left to the professionals.
In this article: KND
1 to 16 of 4324 Posts
1 2 3 ... 271